The agreement facilitates a partnership to co-develop bone repair products using the eluting bone remodeling capabilities of CERAMENT, an injectable synthetic bone substitute, and the collagen properties of Celgro. They plan on incorporating Celgro into CERAMENT to create a novel bone repair product.
“We are pleased to partner with Orthocell to advance bone healing,” said Lloyd Diamond, CEO of BONESUPPORT. “We believe combining the important collagen properties of Orthocell’s Celgro and the proven remodelling and eluting capabilities of CERAMENT will enable us to develop novel regenerative technologies and treatments to further bone regeneration.”
More articles on devices:
VEXIM’s Masterflow Injection System for orthopedic cement gains FDA clearance
RTI Surgical’s EVP of Administration Thomas Rose to retire: 3 quick facts
EOS imaging’s hipEOS receives FDA approval
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
